Early response of tumour to radiotherapy should be assessed by both uptake and retention of single photon tracers: In vitro analysis with 201tl-chloride, 99tcm-sestamibi and 99tcm-tetrofosmin in human bladder cancer cells and human leukocytes

Nuclear Medicine Communications

Volumn 20, Issue 6, 1999, Pages 581-588

  Kinuya, S ^a   Yokoyama, K ^a   Watanabe, N ^b   Hiramatsu, T ^a   Tega, H ^a   Konishi, S ^a   Shuke, N ^c   Aburano, T ^c   Michigishi, T ^a   Tonami, N ^a   Takayama, T ^d  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PERTECHNETIC ACID TC 99M; TETROFOSMIN TC 99M; THALLIUM CHLORIDE TL 201;

ARTICLE; BLADDER CANCER; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG RETENTION; DRUG UPTAKE; HUMAN; HUMAN CELL; LEUKOCYTE; RADIATION DOSE;

HUMANS; LEUKOCYTES; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; THALLIUM; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0032736460     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199906000-00014     Document Type: Article

References (24)

1. 201T1 scintigraphy in the evaluation of lung lesions and post-therapy follow-up of primary lung carcinoma. Nncl Med Commun 1993; 14: 446-453.
2. Namba R, Narabayashi I, Matsui R et al. Evaluation of Tl-201 SPECT for monitoring the treatment of pulmonary and mediastinal tumors. Ann Nucl Med 1995; 9: 65-74.
3. 201T1 SPET to predict the response to radiotherapy in patients with head and neck cancer. Nucl Med Commun 1996; 17: 935-942.
4. 201Tl-chloride scintigraphy for monitoring radiotherapeutic effects. Nucl Med Commun 1994; 15: 128-139.
5. Togawa T, Yui N, Kinoshita F et al. Thallium-201 single-photon emission tomography in the treatment follow-up of nasopharyngeal carcinoma. Eur J Nucl Med 1997; 24: 305-311.
6. Shimizu M, Seto H, Kageyama M et al. Assessment of treatment response in irradiated lung cancer by sequential thallium-201 SPECT: Comparison with tumor volume change and survival time. Radiat Med 1996; 14: 7-12.
7. Nishizawa K, Okunieff P, Elmaleh D, McKusick KA, Strauss HW, Suit HD. Blood flow of human soft tissue sarcomas measured by thallium-201 scanning: Prediction of tumor response to radiation. Int j Radiat Oncol Biol Phys 1991; 20: 593-597.
8. Vertosick FT, Selker RG, Grossman SJ, Joyce JM. Correlation of thallium-201 single photon emission computed tomography and survival after treatment failure in patients with glioblastoma multiforme. Neurosurgery 1994; 34: 396-401.
9. Kosuda S, Fujimi H, Aoki S et al. Prediction of survival in patients with suspected recurrent cerebral tumors by quantitative thallium-201 single photon emission computed tomography. Int. J Radiat Oncol Biol Phys 1994; 30: 1201-1206.
10. Kostakoglu L, Uysal U, Özyar E et al. Monitoring response to therapy with thallium-201 and. technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma. J Nucl Med 1997; 38: 1009-1014.
11. Higashi K, Clavo AC, Wahl RK. In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy. J Nucl Med 1993; 34: 773-779.
12. Hautzel H, Müller-Gärtner H-W. Early changes in fluorine-18-FDG uptake during radiotherapy. J Nucl Med 1997; 38: 1384-1386.
13. Furuta M, Hasegawa M, Hayakawa K et al. Rapid rise in FDG uptake in an irradiated human tumour xenograft. Eur J Nucl Med 1997; 24: 435-438.
14. 201T1 in tumor bearing animals and inflammatory lesion induced animals. Eur J Nucl Med 1987; 12: 567-572.
15. Kubota K, Matsuzawa T, Takahashi T et al. Rapid and sensitive response of carbon-ll-L-methionine tumor uptake to irradiation. J Nucl Med 1989; 30: 2012-2016.
16. Tomura N, Hirano H, Watanabe O et al. Evaluation of single photon emission computed tomography of tumors in the head and neck with technetium-99m MIBI. Kaku Igaku 1997; 34: 471-479.
17. Basoglu T, Şahin M, Coskun C, Koparan A, Bernay I, Erkan L. Technetium-99m-tetrofosmin uptake in malignant lung tumors. Eur J Nucl Med 1995; 22: 687-689.
18. Kostakoglu L, Uysal U, Özyar E et al. A comparative study of technetium-99m-sestamibi and technetium-99m-tetrofosmin single-photon tomography in the detection of nasopharyngeal carcinoma. Eur J Nucl Med 1997; 24: 621-628.
19. Oriuchi N, Tamura M, Shibazaki T et al. Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: Relationship to histologic grade, prognosis and proliferative activities. J Nucl Med 1993; 34: 2085-2089.
20. Ishibashi M, Taguchi A, Sugita Y et al. Thallium-201 in brain tumors: Relationship between tumor cell activity in astrocytic tumor and proliferating cell nuclear antigen. J Nucl Med 1995; 36: 2201-2206.
21. Kinuya S, Takahashi S, Saito M, Tofuku Y, Michigishi T, Tonami N. Intense and prolonged Tl-201 accumulation in a slow growing bronchioloalveolar carcinoma. Ann Nucl Med 1996; 10: 261-264.
22. Archer EG. Inactivation of amino acid transport systems in Ehrlich ascites carcinoma cells by cobalt-60 gamma radiation. Radiat Res 1968; 35: 109-122.
23. Arbab AS, Koizumi K, Toyama K, Araki T. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. J Nucl Med 1996; 37: 1551-1556.
24. 20IT1 in a tumour cell line. Nucl Med Commun 1997; 18: 235-240.